E-LIB Suche - Ergebnisse für: Stroes, Erik

1

Evinacumab in homozygous familial hypercholesterolaemia: lo..:

Gaudet, Daniel ; Greber-Platzer, Susanne ; Reeskamp, Laurens F...
European Heart Journal. 45 (2024) 27 - p. 2422-2434 , 2024

Link: https://doi.org/10.1093/..

2

Accumulation of Iron Oxide-Based Contrast Agents in Rabbit ..:

Sekita, Alexander ; Unterweger, Harald ; Berg, Sonja...
International Journal of Nanomedicine. 19 (2024) - p. 1645-1666 , 2024

Link: https://doi.org/10.2147/..

3

Comparative in vitro and in vivo Evaluation of Different Ir..:

Unterweger, Harald ; Janko, Christina ; Folk, Tamara...
International Journal of Nanomedicine. 18 (2023) - p. 2071-2086 , 2023

Link: https://doi.org/10.2147/..

4

The Long-Term Efficacy and Safety of Evinacumab in Patients..:

Raal, Frederick J. ; Rosenson, Robert S. ; Reeskamp, Laurens F....
JACC: Advances. 2 (2023) 9 - p. 100648 , 2023

Link: https://doi.org/10.1016/..

5

Efficacy and Safety of Subcutaneous Garadacimab for the Pro..:

Craig, Timothy ; Magerl, Markus ; Reshef, Avner...
Journal of Allergy and Clinical Immunology. 151 (2023) 2 - p. AB132 , 2023

Link: https://doi.org/10.1016/..

6

Evinacumab Markedly Reduces Low-density Lipoprotein Cholest..:

Reeskamp, Laurens ; Greber-Platzer, Susanne ; Saheb, Samir...
Journal of Clinical Lipidology. 16 (2022) 1 - p. e19 , 2022

Link: https://doi.org/10.1016/..

7

Duodenal Anaerobutyricum soehngenii infusion stimulates GLP..:

Koopen, Annefleur ; Witjes, Julia ; Wortelboer, Koen...
Gut. , 2021

Link: https://doi.org/10.1136/..

8

Factors that Influence Bempedoic Acid-Mediated Reductions i..:

Stroes, Erik ; Bays, Harold ; Banach, Maciej...
Journal of Clinical Lipidology. 14 (2020) 4 - p. 577 , 2020

Link: https://doi.org/10.1016/..

9

A Comparison of Ezetimibe and Evolocumab for Atherogenic Li..:

Koren, Michael J. ; Jones, Peter H. ; Robinson, Jennifer G....
Cardiology and Therapy. 9 (2020) 2 - p. 447-465 , 2020

Link: https://doi.org/10.1007/..

10

Consistent LDL‐C response with evolocumab among patient sub..:

Stroes, Erik ; Robinson, Jennifer G. ; Raal, Frederick J....
Clinical Cardiology. 41 (2018) 10 - p. 1328-1335 , 2018

Link: https://doi.org/10.1002/..

11

Identifying the anti-inflammatory response to lipid lowerin..:

Tuñón, José ; Badimón, Lina ; Bochaton-Piallat, Marie-Luce...
Cardiovascular Research. 115 (2018) 1 - p. 10-19 , 2018

Link: https://doi.org/10.1093/..

12

Identification and diagnosis of patients with familial chyl..:

Moulin, Philippe ; Dufour, Robert ; Averna, Maurizio...
Atherosclerosis. 275 (2018) - p. 265-272 , 2018

Link: https://doi.org/10.1016/..

13

The APPROACH Study: A Randomized, Double-Blind, Placebo-Con..:

Gaudet, Daniel ; Digenio, Andres ; Alexander, Veronica J....
Atherosclerosis Supplements. 32 (2018) - p. 14-15 , 2018

Link: https://doi.org/10.1016/..

14

Characterisation of patients with familial chylomicronaemia..:

Moulin, Philippe ; Dufour, Robert ; Averna, Maurizio...
Data in Brief. 21 (2018) - p. 1334-1336 , 2018

Link: https://doi.org/10.1016/..

15

Treatment with Volanesorsen (VLN) Reduced Triglycerides and..:

Gelrud, Andres ; Digenio, Andres ; Alexander, Veronica J....
Atherosclerosis Supplements. 32 (2018) - p. 157 , 2018

Link: https://doi.org/10.1016/..